Cardillo, Carmine
 Distribuzione geografica
Continente #
NA - Nord America 1.632
EU - Europa 1.616
AS - Asia 443
OC - Oceania 6
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 2
Totale 3.707
Nazione #
US - Stati Uniti d'America 1.624
DE - Germania 335
PL - Polonia 308
SE - Svezia 234
CN - Cina 205
IT - Italia 192
UA - Ucraina 182
IE - Irlanda 98
SG - Singapore 77
RU - Federazione Russa 72
FR - Francia 64
ID - Indonesia 57
FI - Finlandia 53
IN - India 51
GB - Regno Unito 38
TR - Turchia 24
BE - Belgio 21
IR - Iran 10
AU - Australia 5
CA - Canada 4
CH - Svizzera 4
JP - Giappone 4
KR - Corea 4
NL - Olanda 4
VN - Vietnam 4
CZ - Repubblica Ceca 3
ES - Italia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CL - Cile 2
CO - Colombia 2
DK - Danimarca 2
GT - Guatemala 2
IQ - Iraq 2
MX - Messico 2
MY - Malesia 2
RO - Romania 2
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BR - Brasile 1
CI - Costa d'Avorio 1
EU - Europa 1
JO - Giordania 1
LY - Libia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
Totale 3.707
Città #
Warsaw 306
Chandler 291
Ashburn 150
Dublin 91
Fairfield 79
San Mateo 79
Jacksonville 77
Ann Arbor 74
Wilmington 71
Houston 67
Woodbridge 65
Singapore 57
Jakarta 56
New York 54
Seattle 46
Nanjing 44
Cattolica 41
Boston 36
Beijing 34
Milan 34
Lawrence 33
Marseille 30
Moscow 30
Saint Petersburg 30
Dearborn 28
Nanchang 28
Rome 27
Cambridge 24
Redwood City 20
Princeton 18
Munich 17
Bremen 16
Helsinki 16
Mountain View 15
Brussels 14
Izmir 12
Los Angeles 11
Lancaster 9
Norwalk 9
University Park 9
Boardman 8
Changsha 8
Hangzhou 8
Hebei 8
Jiaxing 8
Nürnberg 8
Shenyang 8
Tianjin 8
Bursa 7
Busto Arsizio 7
Pune 7
Fremont 6
Corbetta 5
Kunming 5
San Diego 5
Washington 5
Hefei 4
Leawood 4
Brno 3
Detroit 3
Dong Ket 3
Gent 3
Jinan 3
Kish 3
London 3
Millbury 3
Redmond 3
Shanghai 3
Simi Valley 3
Toronto 3
Acton 2
Albuquerque 2
Ankara 2
Augusta 2
Brisbane 2
Chicago 2
Chiswick 2
Fonte Nuova 2
Groningen 2
Guangzhou 2
Guatemala City 2
Indiana 2
Madrid 2
Menlo Park 2
Napoli 2
Nuremberg 2
Phoenix 2
Sacramento 2
Southend 2
Tappahannock 2
Zhengzhou 2
Zurich 2
Abidjan 1
Agrate Brianza 1
Amman 1
Amsterdam 1
Andover 1
Ardabil 1
Arezzo 1
Auckland 1
Totale 2.355
Nome #
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis 319
Human obesity and endothelium-dependent responsiveness 271
Obesity is associated with in vivo platelet activation and impaired responsiveness to once-daily, low-dose aspirin 138
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes 130
Effects of GLP-1 on Forearm Vasodilator Function and Glucose Disposal During Hyperinsulinemia in the Metabolic Syndrome 119
Mesothelioma in Familial Mediterranean Fever With Colchicine Intolerance: A Case Report and Literature Review 100
Selective cardiac neuroadrenergic abnormalities in hypertensive patients with left ventricular hypertrophy 97
Vascular Effects of Obestatin in Lean and Obese Subjects 93
Coexistence of functional angiotensin II type 2 receptors mediating both vasoconstriction and vasodilation in humans 90
Ghrelin Restores the Endothelin 1/Nitric Oxide Balance in Patients With Obesity-Related Metabolic Syndrome 82
Beneficial Effects of Apelin on Vascular Function in Patients with Central Obesity 81
Improved Endothelial Function After Endothelin Receptor Blockade in Patients With Systemic Sclerosis 79
Ghrelin restores the endothelin 1/nitric oxide balance in patients with obesity-related metabolic syndrome. 75
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis 75
Endothelial and perivascular adipose tissue abnormalities in obesity-related vascular dysfunction: novel targets for treatment 75
Favorable Vascular Actions of Angiotensin-(1-7) in Human Obesity 74
Vasodilator responses and endothelin-dependent vasoconstriction in metabolically healthy obesity and the metabolic syndrome. 73
CD26: a multi-purpose pharmacological target 71
Tumor necrosis factor-alpha antagonism improves vasodilation during hyperinsulinemia in metabolic syndrome 70
Leptin stimulates both endothelin-1 and nitric oxide activity in lean subjects but not in patients with obesity-related metabolic syndrome 70
Obesity and kidney disease: Beyond the hyperfiltration 70
Favorable Vascular Actions of Angiotensin-(1-7) in Human Obesity 63
Rho Kinase Inhibition Improves Forearm Vasodilator Responsiveness During Hyperinsulinemia in the Metabolic Syndrome. 60
PPARγ activation does not affect endothelin activity in non-diabetic patients with hypertension or hypercholesterolemia 60
Vasodilator responses and endothelin-dependent vasoconstriction in metabolically healthy obesity and the metabolic syndrome 59
Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease 58
Gut hormones and endothelial dysfunction in patients with obesity and diabetes 57
Generalized impairment of vasodilator reactivity during hyperinsulinemia in patients with obesity-related metabolic syndrome 55
Vascular hyperpolarization in human physiology and cardiovascular risk conditions and disease 51
Oxidative stress in diabetes: implications for vascular and other complications 49
Increased fractalkine and vascular dysfunction in obesity and in type 2 diabetes. Effects of oral antidiabetic treatment 49
Insulinemia and the risk of breast cancer and its relapse 48
Obesity, blood vessels and metabolic syndrome 48
Vascular hyperpolarization in human physiology and cardiovascular risk conditions and disease 48
Mechanisms of SGLT2 (Sodium-Glucose Transporter Type 2) Inhibition-Induced Relaxation in Arteries From Human Visceral Adipose Tissue 47
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis 45
Arterial ageing: from endothelial dysfunction to vascular calcification 45
Calcification biomarkers and vascular dysfunction in obesity and type 2 diabetes: influence of oral hypoglycemic agents. 45
Osteoprotegerin and outcomes in acute coronary syndromes--when the culprit is not the plaque 44
Increased endothelin-1-mediated vasoconstrictor tone in human obesity: effects of gut hormones 43
Vasodilator Dysfunction in Human Obesity: Established and Emerging Mechanisms 43
Deterioration of glucose homeostasis in type 2 diabetic patients one year after beginning of statins therapy 42
Generalized impairment of vasodilator reactivity during hyperinsulinemia in patients with obesity-related metabolic syndrome 41
Drug treatments to restore vascular function and diabesity 41
Sex-specific effects of cardiovascular risk factors on endothelium-dependent dilation and endothelin activity in middle-aged women and men. 40
The vascular endothelin system in obesity and type 2 diabetes: Pathophysiology and therapeutic implications 38
Exercise is medicine: key to cardiovascular disease and diabetes prevention 38
Lp-PLA 2 , a new biomarker of vascular disorders in metabolic diseases 36
Osteoprotegerin and outcomes in acute coronary syndromes--when the culprit is not the plaque 33
Metabolic profiling of visceral adipose tissue from obese subjects with or without metabolic syndrome. 32
Variable changes of circulating angptl3 and angptl4 in different obese phenotypes: Relationship with vasodilator dysfunction 32
Intricacies of the endothelin system in human obesity: Role in the development of complications and potential as a therapeutic target 32
Variable dysregulation of circulating lipocalin-2 in different obese phenotypes: Association with vasodilator dysfunction 29
Obesity is associated with impaired responsiveness to once-daily low-dose aspirin and in vivo platelet activation 28
Mirabegron relaxes arteries from human visceral adipose tissue through antagonism of α1-adrenergic receptors 17
Association of Gut Hormones and Microbiota with Vascular Dysfunction in Obesity 13
Mirabegron relaxes arteries from human visceral adipose tissue through antagonism of α1-adrenergic receptors 9
Totale 3.770
Categoria #
all - tutte 16.063
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.063


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020533 0 0 63 83 27 41 74 26 26 34 111 48
2020/2021464 33 51 11 47 68 59 44 16 64 18 43 10
2021/2022388 33 32 8 17 32 13 5 69 20 29 63 67
2022/2023859 106 110 72 116 50 116 38 72 114 27 27 11
2023/2024485 21 133 14 17 23 82 40 30 7 19 31 68
2024/2025115 21 19 75 0 0 0 0 0 0 0 0 0
Totale 3.770